On Friday, the U.S. Food and Drug Administration (FDA) approved Tonix Pharmaceuticals Holding Corp.’s TNXP Tonmya (cyclobenzaprine HCl sublingual tablets) for fibromyalgia in adults. Fibromyalgia is a chronic condition characterized by widespread musculoskeletal pain, fatigue, and other symptoms like sleep disturbances and cognitive difficulties. Tonmya is a non-opioid, once-daily bedtime analgesic with a unique sublingual (under the tongue) formulation that is …
Read More »What’s Going On With Tonix Pharma Stock Monday? – Tonix Pharmaceuticals (NASDAQ:TNXP)
